Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT07591701

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Video

Study Details

Brief summary:

The main rationale underlying this study is that prostate cancer clinical trials are lacking representation from racial and ethnic minority groups. Study proposal aims to target barriers at the participant, investigator, and health system level through specific interventions to increase the percentage of participants from these backgrounds on cancer clinical trials.

Conditions

Prostate Cancer

Study ID

NCT07591701

Start date

May 26, 2026

Status verified date

Jun, 2026

Completion date

Jan 31, 2030

Anticipated

Primary completion date

Jan 31, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

These criteria include diagnosed prostate cancer patients receiving care at LBJ Hospital who

Are eligible for an open prostate cancer clinical trial at LBJ Hospital during the study period

Can provide informed consent.

Exclusion Criteria:

These criteria include prostate cancer patients receiving care at LBJ who are unable to participate due to a serious psychological or cognitive condition or have a medical condition that prevents participation in the trial.

Study Design

Enrollment

60 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Video Intervention to Prostate Cancer Patient

The interventions will be conducted at Lyndon B. Johnson (LBJ) Hospital, a safety net facility that cares for a majority Latino and/or Black patient population.

experimental: To Conduct Educational Sessions with Frontline Oncology Providers

The investigator will conduct multiple one-hour educational sessions focused on participant-centered communication and cultural competency with the 42 oncology fellows during their academic half-days. Fellows attending the educational sessions will be invited to complete a Likert-style course evaluation form and provide open-ended feedback."

Interventions

Video

Participants will watch a short video in clinic. Participants will complete the two validated scales before and after viewing the video.

Primary outcome measure

  • Safety and Adverse Events (AEs) [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts and Locations

Central contacts

Debanjan Pain, MD

(713) 745-0075dpain@mdanderson.org

Locations

The University of Texas M. D. Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77090

Contacts

Debanjan Pain, MD

713-745-0075dpain@mdanderson.org

Principal Investigator:

Debanjan Pain, MD

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Jun 26, 2026

Last verified

Jun, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-06-26.